Feed Top Reports Pricing

⌘K

00:15:04·604d

SECFiling

SEC Form EFFECT filed by Agile Therapeutics Inc.

AGRX· Agile Therapeutics Inc.

Health Care

Original source

Companies

AGRX
Agile Therapeutics Inc.
Health Care

Recent analyst ratings

Nov 3UpdateHC Wainwright & Co.$2.50
Sep 13UpdateHC Wainwright & Co.$3.50
Jul 27UpdateRBC Capital$5.00

Related

SEC603d
SEC Form RW filed by Agile Therapeutics Inc.
SEC604d
SEC Form EFFECT filed by Agile Therapeutics Inc.
SEC604d
SEC Form EFFECT filed by Agile Therapeutics Inc.
INSIDER605d
Chief Administrative Officer Gilmore Geoffrey returned $30,789 worth of shares to the company (20,256 units at $1.52), closing all direct ownership in the company (SEC Form 4)
INSIDER605d
Chief Financial Officer Coiante Scott M returned $30,522 worth of shares to the company (20,080 units at $1.52), closing all direct ownership in the company (SEC Form 4)
INSIDER605d
Chief Supply Chain Officer Conway Robert G returned $20,564 worth of shares to the company (13,529 units at $1.52), closing all direct ownership in the company (SEC Form 4)
INSIDER605d
Chief Medical Officer Korner Paul returned $20,520 worth of shares to the company (13,500 units at $1.52), closing all direct ownership in the company (SEC Form 4)
INSIDER605d
Chief Commercial Officer Welsh Amy returned $20,520 worth of shares to the company (13,500 units at $1.52), closing all direct ownership in the company (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022